Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUPD.L Regulatory News (SUPD)

  • There is currently no data for SUPD

Final Results

20 Mar 2019 09:51

RNS Number : 4352T
Sunplus Technology Co Limited
20 March 2019
 

Sunplus Technology Company Limited

Consolidated Balance Sheets

Ended December 31, 2018*

(In Thousands of New Taiwan Dollars)

 

Assets

Amount

Liabilities & Shareholders Equity

Amount

Cash & Equivalent

3,235,721

Current Liabilities

1,684,729

Financial assets at fair value through profit or loss-current

1,313,747

Non-Current Liabilities

374,649

Accounts & Notes receivable

954,030

Total Liabilities

2,059,378

Other Receivable

70,960

Equity attributable to owners of the parent

Inventories

818,948

Capital stock

5,919,949

Other current assets

244,896

Shares to be issued

Total Current Assets

6,638,302

Capital surplus

801,398

Appropriated as legal reserve

1,941,826

Financial assets at fair value through profit or loss - non-current

737,867

Appropriated as special reserve

67,279

Financial assets at fair value through other comprehensive income t - non-current

246,208

Unappropriated earnings (deficit)

241,734

Investments accounted for using the equity method

729,219

Others

(442,843)

Property, plant and equipment

2,052,359

Treasury Stock

(63,401)

Investment properties

1,039,314

Total equity attributable to owners of the parent

8,465,942

Intangible Assets-Net

178,521

Deferred tax assets

30,254

Non-Controlling Interests

1,401,664

Other Non-Current Assets

274,940

Total Shareholders¡¦ Equity

9,867,606

Total Non-Current Investments

5,288,682

Total Assets

11,926,984

Total Liabilities & Shareholders' Equity

11,926,984

 

Sunplus Technology Company Limited

Consolidated Statements of Income

From January 1 to December 31, 2018 and 2017

(In Thousands of New Taiwan Dollars, Except Earnings per share) 

Unit: NT$K, Except EPS

2018

2017

YoY

Net sales

6,077,733

6,820,237

(10.89)

Cost

3,648,349

4,083,471

(10.66)

Gross Profit

2,429,384

2,736,766

(11.23)

Marketing Expense

286,562

308,054

(6.98)

General& Administrative Expense

532,943

599,899

(11.16)

R&D Expenses

1,699,345

1,779,383

(4.50)

Other operating income(Expense)

(324)

(2,245)

(85.57)

Total operating income (expense)

(89,790)

47,185

(290.29)

Total non-operating income (expense)

293,780

587,470

(49.99)

Income(loss) before income tax from continued operating units

203,990

634,655

(67.86)

Income tax expense

61,667

83,427

(26.08)

Consolidated Net Income

142,323

551,228

(74.18)

Consolidated Net IncomeAttributable To Shareholders of the parent

5,616

421,458

(98.67)

Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*

0.01

0.72

¡@

* Based on outstanding 588,434,923 shares on 2018/12/31

Sunplus Technology Company Limited

Consolidated Cash Flow Summary

From January 1 to December 31, 2018 and 2017

(In Thousand New Taiwan Dollars)

 

ITEM

2018

2017

Cash Flow in (out) from operating

382,304

314,932

Cash Flow in (out) from Investing

(411,696)

639,607

Cash Flow in (out) from Financing

(895,040)

(1,593,485)

Impact from Fx Change

3,876

(8,272)

Net Increase (Decrease) in Cash & Cash Equivalents

(920,556)

(647,218)

Cash & Cash Equivalents, Beginning of Period

4,156,277

4,803,495

Cash & Cash Equivalents, End of Period

3,235,721

4,156,277

 

 

Spokesman

Wayne Shen

Tel: +886-3-5786005 ext. 2350

E-mail: wayne@sunplus.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR URSKRKVAOURR
Date   Source Headline
18th Jun 201210:14 amRNSResult of AGM
30th Apr 201210:00 amRNS1st Quarter Results
27th Apr 201211:07 amRNSNotice of AGM
22nd Mar 20127:00 amRNSNotice of AGM
22nd Mar 20127:00 amRNSFinal Results
1st Nov 20117:00 amRNS3rd Quarter Results
16th Jun 20117:00 amRNSResult of AGM
3rd May 20117:17 amRNSNotice of AGM
27th Apr 201110:55 amRNS1st Quarter Results
16th Feb 20117:00 amRNSFinal Results
26th Oct 20107:00 amRNS3rd Quarter Results
26th Oct 20107:00 amRNS3rd Quarter Results
28th Jul 20109:00 amRNSHalf Yearly Report
14th Jun 20107:00 amRNSResult of AGM
28th Apr 20107:00 amRNS1st Quarter Results
27th Apr 201010:13 amRNSNotice of AGM
10th Feb 20107:00 amRNSFinal Results
28th Oct 20097:00 amRNS3rd Quarter Results
29th Jul 200910:00 amRNSHalf Yearly Report
30th Apr 200911:16 amRNSResult of AGM
29th Apr 20098:37 amRNS1st Quarter Results
19th Mar 20098:02 amRNSNotice of AGM
19th Mar 20097:55 amRNSFinal Results
26th Feb 20099:30 amRNSFinal Results (Preliminary)
26th Feb 20097:06 amRNSNotice of AGM
29th Oct 20087:00 amRNS3rd Quarter Results
31st Jul 200810:00 amRNSInterim Results
13th Jun 20087:37 amRNSDividend Declaration
30th Apr 20087:00 amRNSDividend Declaration
29th Apr 20088:30 amRNS1st Quarter Results
25th Mar 20087:00 amRNSNotice of AGM
1st Feb 20087:00 amRNSFinal Results
20th Dec 20077:00 amRNSTransfer to PSM
10th Dec 200710:00 amRNSTransfer to PSM
26th Oct 20077:00 amRNS3rd Quarter Results
27th Jul 20078:00 amRNSInterim Results
27th Jul 20078:00 amRNSDividend Declaration
15th Jun 20077:00 amRNSResult of AGM
6th Feb 20077:20 amRNSFinal Results
8th Dec 20067:00 amRNSResult of EGM
1st Dec 20068:23 amRNSRestructure Proposals
19th Oct 200610:49 amRNSCapital Reorganisation
19th Oct 20068:00 amRNS3rd Quarter Results
13th Oct 20067:31 amRNSResult of EGM
19th Sep 20069:01 amRNSNotice of EGM
28th Jul 20067:30 amRNSInterim Results
9th Jun 20062:25 pmRNSDividend Declaration
21st Apr 20062:57 pmRNSNotice of AGM
21st Apr 20068:00 amRNS1st Quarter Results
13th Mar 20069:38 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.